Search - tctmd.com

Displaying 921 - 940 of 1506

Sort: Relevancy | Date

Presentation TCT 2017

TCT 112: Effect of Local Hypothermia on Outcomes in Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention - A Pilot Clinical Study

Presenter: Patrick W. Serruys, Liansheng Wang, MD

November 01, 2017

Presentation TCT 2017

TCT 111: Outcomes of Percutaneous Coronary Intervention for Acute Myocardial Infarction in Female Patients

Presenter: Patrick W. Serruys, Konstantinos Voudris

November 01, 2017

Presentation TCT 2017

TCT 110: Periprocedural Myocardial Infarction and Mortality in Patients Undergoing PCI vs CABG for Left Main Disease - Analysis From the EXCEL Trial

Presenter: Patrick W. Serruys, Ori Ben-Yehuda

November 01, 2017

Presentation TCT 2017

Effect of Local Hypothermia on Outcomes in Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Pilot Clinical Study

Presenter: Dariusz Dudek, Cindy L. Grines, Liansheng Wang

November 01, 2017

Presentation TCT 2017

Pre and Postconditioning to Enhance Myocardial Salvage: 2017 Status

Presenter: Bernard J. Gersh, Michel Ovize, Graham Nichol

October 31, 2017

Presentation TCT 2017

Is Cardioprotection for Acute Myocardial Infarction Dead? The Graveyard of Trials

Presenter: Bernard J. Gersh, Michel Ovize

October 31, 2017

Presentation TCT 2017

Trials With Cardiac Derived Cells: CAREMI and ALLSTAR

Presenter: Francisco Fdez-Aviles, Ricardo Sanz-Ruiz

October 31, 2017

Presentation TCT 2017

TCT 79: What Biomarker Threshold for Periprocedural Myocardial Infarction Following PCI and CABG in Left Main Disease is Prognostically Relevant? Analysis from the EXCEL Trial

Presenter: Davide Capodanno, Tullio Palmerini, Shmuel Chen, MD

October 31, 2017

Presentation TCT 2017

US Trial Background and Update: Preserve-AMI

Presenter: Francisco Fdez-Aviles, Ricardo Sanz-Ruiz, Timothy D. Henry

October 31, 2017

Presentation TCT 2017

The Clinical Point of View: Is There an AMI Need for Cell Therapy?

Presenter: Francisco Fdez-Aviles, Ricardo Sanz-Ruiz, Jose M. de la Torre Hernandez

October 31, 2017

Presentation TCT 2017

TCT 2: Coronary Angiographic Findings and Outcomes in Patients With Sudden Cardiac Arrest Without ST-Elevation Myocardial Infarction - A SWEDEHEART Study

Presenter: Rajesh M. Dave, A. Michael Lincoff, Sasha Koul, MD

October 31, 2017

Presentation TCT 2017

TCT 97: Culprit Lesion vs Multi-Vessel Intervention in Patients With Cardiogenic Shock Complicating Myocardial Infarction: Incidence and Outcomes From the London Heart Attack Group

Presenter: Vladimir Dzavik, Srihari S. Naidu, Krishnaraj Rathod, MD

October 31, 2017

Presentation TCT 2017

TCT 89: Tradeoff Between Myocardial Infarction and Bleeding in Relation to Bleeding Risk - Insights From PARIS Registry

Presenter: Kurt Huber, Jamil Abdalla Saad, Sabato Sorrentino, MD

October 31, 2017

Presentation TCT 2017

TCT 1: Direct Stenting Strategy Is Associated With Improved Outcomes in Patients With Totally Occluded Culprit Arteries Undergoing Primary Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction

Presenter: Rajesh M. Dave, A. Michael Lincoff, Ivan Bessonov, MD

October 31, 2017

News Conference News TCT 2017

No Advantage With Hybrid Revascularization for Multivessel Disease: HREVS

Michael O'Riordan

October 30, 2017

News Conference News TCT 2017

Live From Denver: TCT 2017, Day One

Shelley Wood

October 30, 2017

News Conference News TCT 2017

CULPRIT-SHOCK Disputes Benefit of Immediate Multivessel PCI in Patients With Cardiogenic Shock

Todd Neale

October 30, 2017

News Daily News

Any Stable Troponin T Level Detectable by a High-Sensitivity Assay Signals Higher Death Risk

Todd Neale

October 23, 2017

News Daily News

Bleeding and Ischemic Events Fluctuate Out to 1 Year Post-STEMI: HORIZONS-AMI

Yael L. Maxwell

October 03, 2017

News Daily News

New Performance and Quality Metrics for STEMI and NSTEMI Care

Michael O'Riordan

September 21, 2017

Advertisement

TCT 112: Effect of Local Hypothermia on Outcomes in Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention - A Pilot Clinical Study

TCT 111: Outcomes of Percutaneous Coronary Intervention for Acute Myocardial Infarction in Female Patients

TCT 110: Periprocedural Myocardial Infarction and Mortality in Patients Undergoing PCI vs CABG for Left Main Disease - Analysis From the EXCEL Trial

Effect of Local Hypothermia on Outcomes in Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Pilot Clinical Study

Pre and Postconditioning to Enhance Myocardial Salvage: 2017 Status

Is Cardioprotection for Acute Myocardial Infarction Dead? The Graveyard of Trials

Trials With Cardiac Derived Cells: CAREMI and ALLSTAR

TCT 79: What Biomarker Threshold for Periprocedural Myocardial Infarction Following PCI and CABG in Left Main Disease is Prognostically Relevant? Analysis from the EXCEL Trial

US Trial Background and Update: Preserve-AMI

The Clinical Point of View: Is There an AMI Need for Cell Therapy?

TCT 2: Coronary Angiographic Findings and Outcomes in Patients With Sudden Cardiac Arrest Without ST-Elevation Myocardial Infarction - A SWEDEHEART Study

TCT 97: Culprit Lesion vs Multi-Vessel Intervention in Patients With Cardiogenic Shock Complicating Myocardial Infarction: Incidence and Outcomes From the London Heart Attack Group

TCT 89: Tradeoff Between Myocardial Infarction and Bleeding in Relation to Bleeding Risk - Insights From PARIS Registry

TCT 1: Direct Stenting Strategy Is Associated With Improved Outcomes in Patients With Totally Occluded Culprit Arteries Undergoing Primary Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction

No Advantage With Hybrid Revascularization for Multivessel Disease: HREVS

Live From Denver: TCT 2017, Day One

CULPRIT-SHOCK Disputes Benefit of Immediate Multivessel PCI in Patients With Cardiogenic Shock

Any Stable Troponin T Level Detectable by a High-Sensitivity Assay Signals Higher Death Risk

Bleeding and Ischemic Events Fluctuate Out to 1 Year Post-STEMI: HORIZONS-AMI

New Performance and Quality Metrics for STEMI and NSTEMI Care

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content